NCT04515004 2026-02-17
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer
VA Office of Research and Development
Phase 2 Terminated
Clinical Trials
14 trialsNCT04037462 2024-06-14
Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
VA Office of Research and Development
Phase 1/2 Terminated
NCT03043430 2023-04-25
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
Brooke Army Medical Center
Phase 4 Terminated
NCT05744115 2023-02-24
Ga68-PSMA-11
Harry S. Truman Memorial Veterans' Hospital
Phase 3 Terminated
NCT01505764 2018-07-17
The Role of Ghrelin in Cancer Cachexia
VA Office of Research and Development
Phase 2 Terminated
NCT01574222 2018-01-18
VTNSCLC
VA Office of Research and Development
Phase 1 Terminated
NCT01815463 2016-09-27
NIPCON
Corporal Michael J. Crescenz VA Medical Center
Terminated
NCT02115919 2016-08-19
Safety Study of Multikine in the Treatment of Perianal Warts
United States Naval Medical Center, San Diego
Phase 1 Terminated
NCT01954706 2015-11-26
BCS2
Baltimore VA Medical Center
Phase NA Terminated
NCT00004682 2015-03-25
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
FDA Office of Orphan Products Development
Phase NA Terminated
NCT00557206 2013-11-05
Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer
Minneapolis Veterans Affairs Medical Center
Phase 2 Terminated
NCT00954148 2010-06-30
Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors
Dallas VA Medical Center
Phase NA Terminated
NCT00216424 2007-11-12
Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma
James A. Haley Veterans Administration Hospital
Phase 4 Terminated
NCT00216437 2007-11-12
Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma
James A. Haley Veterans Administration Hospital
Phase 1 Terminated